Global PD-1 Inhibitor Market Growth (Status and Outlook) 2025-2031

September 2025 | 92 pages | ID: G203EA11C1EEN
LP Information

Abstracts

According to this study, the global PD-1 Inhibitor market size will reach US$ 46300 million by 2031.

United States market for PD-1 Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for PD-1 Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for PD-1 Inhibitor is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key PD-1 Inhibitor players cover Merck, Novartis, Onxeo, Sumitomo Dainippon Pharma, Taiwan Liposome Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “PD-1 Inhibitor Industry Forecast” looks at past sales and reviews total world PD-1 Inhibitor sales in 2024, providing a comprehensive analysis by region and market sector of projected PD-1 Inhibitor sales for 2025 through 2031. With PD-1 Inhibitor sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PD-1 Inhibitor industry.

This Insight Report provides a comprehensive analysis of the global PD-1 Inhibitor landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on PD-1 Inhibitor portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PD-1 Inhibitor market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PD-1 Inhibitor and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PD-1 Inhibitor.

This report presents a comprehensive overview, market shares, and growth opportunities of PD-1 Inhibitor market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Pembrolizumab
• Nivolumab
• Atezolizumab
• Durvalumab
• Avelumab
• Others

Segmentation by Application:

• Melanoma
• Non-small Cell Lung Cancer (NSCLC)
• Urothelial Carcinoma
• Classical Hodgkin Lymphoma
• Renal Cell Carcinoma
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck
• Novartis
• Onxeo
• Sumitomo Dainippon Pharma
• Taiwan Liposome Company
• Tiziana Life Sciences
• Genentech (Roche)
• AstraZeneca
• Pfizer

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global PD-1 Inhibitor Market Size (2020-2031)
  2.1.2 PD-1 Inhibitor Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for PD-1 Inhibitor by Country/Region (2020, 2024 & 2031)
2.2 PD-1 Inhibitor Segment by Type
  2.2.1 Pembrolizumab
  2.2.2 Nivolumab
  2.2.3 Atezolizumab
  2.2.4 Durvalumab
  2.2.5 Avelumab
  2.2.6 Others
2.3 PD-1 Inhibitor Market Size by Type
  2.3.1 PD-1 Inhibitor Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global PD-1 Inhibitor Market Size Market Share by Type (2020-2025)
2.4 PD-1 Inhibitor Segment by Application
  2.4.1 Melanoma
  2.4.2 Non-small Cell Lung Cancer (NSCLC)
  2.4.3 Urothelial Carcinoma
  2.4.4 Classical Hodgkin Lymphoma
  2.4.5 Renal Cell Carcinoma
  2.4.6 Others
2.5 PD-1 Inhibitor Market Size by Application
  2.5.1 PD-1 Inhibitor Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global PD-1 Inhibitor Market Size Market Share by Application (2020-2025)

3 PD-1 INHIBITOR MARKET SIZE BY PLAYER

3.1 PD-1 Inhibitor Market Size Market Share by Player
  3.1.1 Global PD-1 Inhibitor Revenue by Player (2020-2025)
  3.1.2 Global PD-1 Inhibitor Revenue Market Share by Player (2020-2025)
3.2 Global PD-1 Inhibitor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PD-1 INHIBITOR BY REGION

4.1 PD-1 Inhibitor Market Size by Region (2020-2025)
4.2 Global PD-1 Inhibitor Annual Revenue by Country/Region (2020-2025)
4.3 Americas PD-1 Inhibitor Market Size Growth (2020-2025)
4.4 APAC PD-1 Inhibitor Market Size Growth (2020-2025)
4.5 Europe PD-1 Inhibitor Market Size Growth (2020-2025)
4.6 Middle East & Africa PD-1 Inhibitor Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas PD-1 Inhibitor Market Size by Country (2020-2025)
5.2 Americas PD-1 Inhibitor Market Size by Type (2020-2025)
5.3 Americas PD-1 Inhibitor Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC PD-1 Inhibitor Market Size by Region (2020-2025)
6.2 APAC PD-1 Inhibitor Market Size by Type (2020-2025)
6.3 APAC PD-1 Inhibitor Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe PD-1 Inhibitor Market Size by Country (2020-2025)
7.2 Europe PD-1 Inhibitor Market Size by Type (2020-2025)
7.3 Europe PD-1 Inhibitor Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa PD-1 Inhibitor by Region (2020-2025)
8.2 Middle East & Africa PD-1 Inhibitor Market Size by Type (2020-2025)
8.3 Middle East & Africa PD-1 Inhibitor Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PD-1 INHIBITOR MARKET FORECAST

10.1 Global PD-1 Inhibitor Forecast by Region (2026-2031)
  10.1.1 Global PD-1 Inhibitor Forecast by Region (2026-2031)
  10.1.2 Americas PD-1 Inhibitor Forecast
  10.1.3 APAC PD-1 Inhibitor Forecast
  10.1.4 Europe PD-1 Inhibitor Forecast
  10.1.5 Middle East & Africa PD-1 Inhibitor Forecast
10.2 Americas PD-1 Inhibitor Forecast by Country (2026-2031)
  10.2.1 United States Market PD-1 Inhibitor Forecast
  10.2.2 Canada Market PD-1 Inhibitor Forecast
  10.2.3 Mexico Market PD-1 Inhibitor Forecast
  10.2.4 Brazil Market PD-1 Inhibitor Forecast
10.3 APAC PD-1 Inhibitor Forecast by Region (2026-2031)
  10.3.1 China PD-1 Inhibitor Market Forecast
  10.3.2 Japan Market PD-1 Inhibitor Forecast
  10.3.3 Korea Market PD-1 Inhibitor Forecast
  10.3.4 Southeast Asia Market PD-1 Inhibitor Forecast
  10.3.5 India Market PD-1 Inhibitor Forecast
  10.3.6 Australia Market PD-1 Inhibitor Forecast
10.4 Europe PD-1 Inhibitor Forecast by Country (2026-2031)
  10.4.1 Germany Market PD-1 Inhibitor Forecast
  10.4.2 France Market PD-1 Inhibitor Forecast
  10.4.3 UK Market PD-1 Inhibitor Forecast
  10.4.4 Italy Market PD-1 Inhibitor Forecast
  10.4.5 Russia Market PD-1 Inhibitor Forecast
10.5 Middle East & Africa PD-1 Inhibitor Forecast by Region (2026-2031)
  10.5.1 Egypt Market PD-1 Inhibitor Forecast
  10.5.2 South Africa Market PD-1 Inhibitor Forecast
  10.5.3 Israel Market PD-1 Inhibitor Forecast
  10.5.4 Turkey Market PD-1 Inhibitor Forecast
10.6 Global PD-1 Inhibitor Forecast by Type (2026-2031)
10.7 Global PD-1 Inhibitor Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market PD-1 Inhibitor Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Merck Company Information
  11.1.2 Merck PD-1 Inhibitor Product Offered
  11.1.3 Merck PD-1 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Merck Main Business Overview
  11.1.5 Merck Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis PD-1 Inhibitor Product Offered
  11.2.3 Novartis PD-1 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Onxeo
  11.3.1 Onxeo Company Information
  11.3.2 Onxeo PD-1 Inhibitor Product Offered
  11.3.3 Onxeo PD-1 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Onxeo Main Business Overview
  11.3.5 Onxeo Latest Developments
11.4 Sumitomo Dainippon Pharma
  11.4.1 Sumitomo Dainippon Pharma Company Information
  11.4.2 Sumitomo Dainippon Pharma PD-1 Inhibitor Product Offered
  11.4.3 Sumitomo Dainippon Pharma PD-1 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Sumitomo Dainippon Pharma Main Business Overview
  11.4.5 Sumitomo Dainippon Pharma Latest Developments
11.5 Taiwan Liposome Company
  11.5.1 Taiwan Liposome Company Company Information
  11.5.2 Taiwan Liposome Company PD-1 Inhibitor Product Offered
  11.5.3 Taiwan Liposome Company PD-1 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Taiwan Liposome Company Main Business Overview
  11.5.5 Taiwan Liposome Company Latest Developments
11.6 Tiziana Life Sciences
  11.6.1 Tiziana Life Sciences Company Information
  11.6.2 Tiziana Life Sciences PD-1 Inhibitor Product Offered
  11.6.3 Tiziana Life Sciences PD-1 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Tiziana Life Sciences Main Business Overview
  11.6.5 Tiziana Life Sciences Latest Developments
11.7 Genentech (Roche)
  11.7.1 Genentech (Roche) Company Information
  11.7.2 Genentech (Roche) PD-1 Inhibitor Product Offered
  11.7.3 Genentech (Roche) PD-1 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Genentech (Roche) Main Business Overview
  11.7.5 Genentech (Roche) Latest Developments
11.8 AstraZeneca
  11.8.1 AstraZeneca Company Information
  11.8.2 AstraZeneca PD-1 Inhibitor Product Offered
  11.8.3 AstraZeneca PD-1 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 AstraZeneca Main Business Overview
  11.8.5 AstraZeneca Latest Developments
11.9 Pfizer
  11.9.1 Pfizer Company Information
  11.9.2 Pfizer PD-1 Inhibitor Product Offered
  11.9.3 Pfizer PD-1 Inhibitor Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pfizer Main Business Overview
  11.9.5 Pfizer Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. PD-1 Inhibitor Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. PD-1 Inhibitor Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pembrolizumab
Table 4. Major Players of Nivolumab
Table 5. Major Players of Atezolizumab
Table 6. Major Players of Durvalumab
Table 7. Major Players of Avelumab
Table 8. Major Players of Others
Table 9. PD-1 Inhibitor Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global PD-1 Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 11. Global PD-1 Inhibitor Market Size Market Share by Type (2020-2025)
Table 12. PD-1 Inhibitor Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global PD-1 Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 14. Global PD-1 Inhibitor Market Size Market Share by Application (2020-2025)
Table 15. Global PD-1 Inhibitor Revenue by Player (2020-2025) & ($ millions)
Table 16. Global PD-1 Inhibitor Revenue Market Share by Player (2020-2025)
Table 17. PD-1 Inhibitor Key Players Head office and Products Offered
Table 18. PD-1 Inhibitor Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global PD-1 Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 22. Global PD-1 Inhibitor Market Size Market Share by Region (2020-2025)
Table 23. Global PD-1 Inhibitor Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global PD-1 Inhibitor Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas PD-1 Inhibitor Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas PD-1 Inhibitor Market Size Market Share by Country (2020-2025)
Table 27. Americas PD-1 Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas PD-1 Inhibitor Market Size Market Share by Type (2020-2025)
Table 29. Americas PD-1 Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas PD-1 Inhibitor Market Size Market Share by Application (2020-2025)
Table 31. APAC PD-1 Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC PD-1 Inhibitor Market Size Market Share by Region (2020-2025)
Table 33. APAC PD-1 Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC PD-1 Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe PD-1 Inhibitor Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe PD-1 Inhibitor Market Size Market Share by Country (2020-2025)
Table 37. Europe PD-1 Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe PD-1 Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa PD-1 Inhibitor Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa PD-1 Inhibitor Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa PD-1 Inhibitor Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of PD-1 Inhibitor
Table 43. Key Market Challenges & Risks of PD-1 Inhibitor
Table 44. Key Industry Trends of PD-1 Inhibitor
Table 45. Global PD-1 Inhibitor Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global PD-1 Inhibitor Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global PD-1 Inhibitor Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global PD-1 Inhibitor Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Merck Details, Company Type, PD-1 Inhibitor Area Served and Its Competitors
Table 50. Merck PD-1 Inhibitor Product Offered
Table 51. Merck PD-1 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Merck Main Business
Table 53. Merck Latest Developments
Table 54. Novartis Details, Company Type, PD-1 Inhibitor Area Served and Its Competitors
Table 55. Novartis PD-1 Inhibitor Product Offered
Table 56. Novartis PD-1 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Novartis Main Business
Table 58. Novartis Latest Developments
Table 59. Onxeo Details, Company Type, PD-1 Inhibitor Area Served and Its Competitors
Table 60. Onxeo PD-1 Inhibitor Product Offered
Table 61. Onxeo PD-1 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Onxeo Main Business
Table 63. Onxeo Latest Developments
Table 64. Sumitomo Dainippon Pharma Details, Company Type, PD-1 Inhibitor Area Served and Its Competitors
Table 65. Sumitomo Dainippon Pharma PD-1 Inhibitor Product Offered
Table 66. Sumitomo Dainippon Pharma PD-1 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Sumitomo Dainippon Pharma Main Business
Table 68. Sumitomo Dainippon Pharma Latest Developments
Table 69. Taiwan Liposome Company Details, Company Type, PD-1 Inhibitor Area Served and Its Competitors
Table 70. Taiwan Liposome Company PD-1 Inhibitor Product Offered
Table 71. Taiwan Liposome Company PD-1 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Taiwan Liposome Company Main Business
Table 73. Taiwan Liposome Company Latest Developments
Table 74. Tiziana Life Sciences Details, Company Type, PD-1 Inhibitor Area Served and Its Competitors
Table 75. Tiziana Life Sciences PD-1 Inhibitor Product Offered
Table 76. Tiziana Life Sciences PD-1 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Tiziana Life Sciences Main Business
Table 78. Tiziana Life Sciences Latest Developments
Table 79. Genentech (Roche) Details, Company Type, PD-1 Inhibitor Area Served and Its Competitors
Table 80. Genentech (Roche) PD-1 Inhibitor Product Offered
Table 81. Genentech (Roche) PD-1 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Genentech (Roche) Main Business
Table 83. Genentech (Roche) Latest Developments
Table 84. AstraZeneca Details, Company Type, PD-1 Inhibitor Area Served and Its Competitors
Table 85. AstraZeneca PD-1 Inhibitor Product Offered
Table 86. AstraZeneca PD-1 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. AstraZeneca Main Business
Table 88. AstraZeneca Latest Developments
Table 89. Pfizer Details, Company Type, PD-1 Inhibitor Area Served and Its Competitors
Table 90. Pfizer PD-1 Inhibitor Product Offered
Table 91. Pfizer PD-1 Inhibitor Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. PD-1 Inhibitor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global PD-1 Inhibitor Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. PD-1 Inhibitor Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. PD-1 Inhibitor Sales Market Share by Country/Region (2024)
Figure 8. PD-1 Inhibitor Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global PD-1 Inhibitor Market Size Market Share by Type in 2024
Figure 10. PD-1 Inhibitor in Melanoma
Figure 11. Global PD-1 Inhibitor Market: Melanoma (2020-2025) & ($ millions)
Figure 12. PD-1 Inhibitor in Non-small Cell Lung Cancer (NSCLC)
Figure 13. Global PD-1 Inhibitor Market: Non-small Cell Lung Cancer (NSCLC) (2020-2025) & ($ millions)
Figure 14. PD-1 Inhibitor in Urothelial Carcinoma
Figure 15. Global PD-1 Inhibitor Market: Urothelial Carcinoma (2020-2025) & ($ millions)
Figure 16. PD-1 Inhibitor in Classical Hodgkin Lymphoma
Figure 17. Global PD-1 Inhibitor Market: Classical Hodgkin Lymphoma (2020-2025) & ($ millions)
Figure 18. PD-1 Inhibitor in Renal Cell Carcinoma
Figure 19. Global PD-1 Inhibitor Market: Renal Cell Carcinoma (2020-2025) & ($ millions)
Figure 20. PD-1 Inhibitor in Others
Figure 21. Global PD-1 Inhibitor Market: Others (2020-2025) & ($ millions)
Figure 22. Global PD-1 Inhibitor Market Size Market Share by Application in 2024
Figure 23. Global PD-1 Inhibitor Revenue Market Share by Player in 2024
Figure 24. Global PD-1 Inhibitor Market Size Market Share by Region (2020-2025)
Figure 25. Americas PD-1 Inhibitor Market Size 2020-2025 ($ millions)
Figure 26. APAC PD-1 Inhibitor Market Size 2020-2025 ($ millions)
Figure 27. Europe PD-1 Inhibitor Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa PD-1 Inhibitor Market Size 2020-2025 ($ millions)
Figure 29. Americas PD-1 Inhibitor Value Market Share by Country in 2024
Figure 30. United States PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC PD-1 Inhibitor Market Size Market Share by Region in 2024
Figure 35. APAC PD-1 Inhibitor Market Size Market Share by Type (2020-2025)
Figure 36. APAC PD-1 Inhibitor Market Size Market Share by Application (2020-2025)
Figure 37. China PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 41. India PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe PD-1 Inhibitor Market Size Market Share by Country in 2024
Figure 44. Europe PD-1 Inhibitor Market Size Market Share by Type (2020-2025)
Figure 45. Europe PD-1 Inhibitor Market Size Market Share by Application (2020-2025)
Figure 46. Germany PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 47. France PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 48. UK PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa PD-1 Inhibitor Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa PD-1 Inhibitor Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa PD-1 Inhibitor Market Size Market Share by Application (2020-2025)
Figure 54. Egypt PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries PD-1 Inhibitor Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 60. APAC PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 61. Europe PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 63. United States PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 64. Canada PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 65. Mexico PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 66. Brazil PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 67. China PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 68. Japan PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 69. Korea PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 71. India PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 72. Australia PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 73. Germany PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 74. France PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 75. UK PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 76. Italy PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 77. Russia PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 78. Egypt PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 79. South Africa PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 80. Israel PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 81. Turkey PD-1 Inhibitor Market Size 2026-2031 ($ millions)
Figure 82. Global PD-1 Inhibitor Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global PD-1 Inhibitor Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries PD-1 Inhibitor Market Size 2026-2031 ($ millions)